Meta-narrative review of molecular methods for diagnosis and monitoring of multidrug-resistant tuberculosis treatment in adults

Show simple item record

dc.contributor.author Mbelele, P.M.
dc.contributor.author Mohamed, S.Y.
dc.contributor.author Sauli, E.
dc.contributor.author Mpolya, E.A.
dc.contributor.author Mfinanga, S.G.
dc.contributor.author Addo, K.K.
dc.contributor.author Heysell, S.K.
dc.contributor.author Mpagama, S.G.
dc.date.accessioned 2019-06-26T12:50:41Z
dc.date.available 2019-06-26T12:50:41Z
dc.date.issued 2018-10
dc.identifier.other DOI: 10.4103/ijmy.ijmy_135_18
dc.identifier.other Vol.7(4): pp 299
dc.identifier.uri http://ugspace.ug.edu.gh/handle/123456789/31057
dc.description.abstract Early and accurate diagnosis and rigorous clinical and microbiological monitoring of multidrug-resistant tuberculosis (MDR-TB) treatment can curb morbidity and mortality. While others are still under evaluation, the World Health Organization has recommended few novel molecular methods for MDR-TB diagnosis only. We present current molecular methods for diagnosis and monitoring of MDR-TB treatment in TB-endemic settings. A systematic meta-narrative review was conducted according to the RAMESES recommendations. Electronic databases were searched for relevant articles published in English language from January 2013 to June 2018. Based on predefined criteria, two independent reviewers extracted the key messages from relevant articles. Disagreement between them was resolved through discussion and the involvement of a third reviewer, if needed. Key messages were synthesized to create the meta-narratives for method's accuracy, drug-susceptibility capability, and laboratory infrastructure required. We included 33 articles out of 1213 records retrieved, of which 16 (48%) and 12 (36%) were conducted in high- and low-TB-endemic settings, respectively. Xpert® MTB/RIF, GenoType MTBDRplus, GenoType MTBDRsl, FlouroType™ MTBDR, TB TaqMan® array card, and DNA sequencers can accurately guide effective treatment regimens. Molecular bacterial load assay quantifies mycobactericidal impact of these regimens. Although they present inherent advantages compared to the current standard of care, they carry important limitations to implementation and/or scale-up. Therefore, considerable effort must now be directed to implementation and health systems research to maximize these forecasted benefits for individual patient's health outcomes. en_US
dc.language.iso en en_US
dc.publisher International Journal of Mycobacteriology en_US
dc.subject Anti-tuberculosis therapy en_US
dc.subject Diagnosis en_US
dc.subject Drug-resistant tuberculosis en_US
dc.subject Molecular methods en_US
dc.subject Monitoring en_US
dc.title Meta-narrative review of molecular methods for diagnosis and monitoring of multidrug-resistant tuberculosis treatment in adults en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • Bacteriology Department [108]
    The Bacteriology Department aims to improve the quality of life first for Ghanaians and the world at large by conducting research into bacterial diseases of public health importance to Ghana and globally. In addition to working on enteric pathogens and sexually transmitted diseases, the department’s current main focus is on the two most important mycobacterial diseases of public health importance to Ghana, namely Buruli ulcer (BU) and tuberculosis (TB).

Show simple item record

Search UGSpace


Browse

My Account